Saturday 17 October 2026
Export CABR’s income statement to Excel — free account
Caring Brands, Inc.
CABR Healthcare Drug Manufacturers Specialty & Generic
Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024. In the quarter to June 2026, EPS fell 102.0% and free cash flow fell 121.3%, each against the same quarter a year earlier.
1.22
0.07
−5.43%
Follow CABR
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | — | 0.71 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | — | 1.65 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | — | 3 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 0 | 0 | ||||
| Gross margin, % | — | — | — | — | — | — | — | — | (320.00) | 54.76 | |||||
| EBT | — | — | — | — | — | — | — | — | (2) | (6) | |||||
| EBT margin, % | — | — | — | — | — | — | — | — | (303,480.00) | (149,480.95) | |||||
| Net income | — | — | — | — | — | — | — | — | (2) | (6) | |||||
| Depreciation | — | — | — | — | — | — | — | — | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | 0.00 | 0.00 | ||||
| Earnings | — | — | — | — | — | — | — | — | (0.12) | (0.46) | |||||
| Cash flow | — | — | — | — | — | — | — | — | (0.06) | (0.12) | |||||
| Capex | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| Free cash flow | — | — | — | — | — | — | — | — | (0.06) | (0.12) | |||||
| Book value | — | — | — | — | — | — | — | — | 0.28 | 0.15 | |||||
| Shares, m | — | — | — | — | — | — | — | — | 13 | 14 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | — | 0.00 | 2,777.62 | |||||
| P/B | — | — | — | — | — | — | — | — | 4.29 | 5.58 | |||||
| EV/Sales | — | — | — | — | — | — | — | — | 0.00 | 2,270.35 | |||||
| EV/FCF | — | — | — | — | — | — | — | — | (12.32) | (5.63) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | (1) | (2) | ||||
| Capex | — | — | — | — | — | — | — | — | — | — | |||||
| Free cash flow | — | — | — | — | — | — | — | — | (1) | (2) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | 0 | 2 | ||||
| Total debt | — | — | — | — | — | — | — | — | — | 0 | |||||
| Net debt | — | — | — | — | — | — | — | — | 0 | (2) | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | 4 | 2 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | 0.00 | (202.38) | ||||
| ROIC | — | — | — | — | — | — | — | — | (29.62) | 0.00 | |||||
| ROE | — | — | — | — | — | — | — | — | 0.00 | (217.14) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Dec 2025
Charts ten years each
Caring Brands, Inc. vs peers (Q) = latest quarter vs a year earlier
Caring Brands, Inc. (CABR) key facts
- Strength: Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024.
- Caring Brands, Inc. (CABR) is a Drug Manufacturers Specialty & Generic company in the Healthcare sector, listed on Nasdaq.
- Return on equity was −217.1% and debt-to-equity 0.00.
- Its Altman Z-score is 18.05 (safe zone) for fiscal 2025.
Caring Brands, Inc. (CABR) Latest News
No news at this impact. Lower the threshold for more.